Treat Stroke to Target "TST"

Recruiting

Phase N/A Results N/A

Summary of Purpose

The aim of this study is the evaluation of two usual care strategies after stroke or TIA : achieved target LDL-C of 100 mg/dL (+/-10 mg/dL) or less than 70 mg/dL. Investigators will use the statin and titrate the dosage to achieve the target assigned by randomization in monotherapy or in combination with ezetimibe or other drugs. The primary end-point is the occurrence of recurrent non fatal stroke, non fatal...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 17 May 2016.

1 Mar 2010 2 Dec 2010 1 Dec 2018 1 Dec 2018 1 May 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Intervention: Parallel Assignment

Contacts